Scholars Central

Short communicationPublished 25 Jan 2018

Thrombotic and bleeding risks: how best to balance in real world

Authors: Syed Raza

Stem Cell Research and Regenerative Medicine

Volume 1 · Issue 1 · Pages 02

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Antithrombotic treatment has revolutionized the medical management of cardiac patients. Over the past 20 years, the improvement of recent anti-thrombotic medications and schemes has decreased ischemic events very significantly. With every approach to decrease thrombosis, however, there is an accompanying risk of improving bleeding complications. Conversely, decreasing bleeding complications may increase thrombotic (ischemic) events. Due to increasing number of elderly populations, prevalence of thrombosis related complications and bleeding combined with anti-thrombotic therapy is constantly increasing. There are various tools to evaluate thrombotic risk but evaluation of bleeding risk is often neglected. Thrombosis and bleeding both increase impairment and death or mortality. Balancing both ends of the spectrum is important and a single approach to therapy is advocated. The author will show various strategies to stable the thrombotic and bleeding risk assessment. This demonstration will be of interest to physicians, cardiologists, haematologists, surgeons, anaesthetists and nurses.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Stem Cell Research and Regenerative Medicine.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalStem Cell Research and Regenerative Medicine
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Syed Raza”